http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101881175-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-77 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765 |
filingDate | 2011-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101881175-B1 |
titleOfInvention | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
abstract | The present invention relates generally to the field of therapy and more particularly to the field of therapy for herpes simplex and herpes zoster and more particularly to the treatment of herpes simplex and herpes zoster, The topical administration of a composition comprising PEG reduces the recurrence rate of cleft herpes (lingual cold sore), genital herpes (genital herpes), and herpes zoster (shingles, zona) Delay of recurrence, and / or prevention of recurrence. |
priorityDate | 2010-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 587.